Shelly is a Project Director at ANSIRH, managing research studies focused on access to sexual and reproductive health care. She currently directs studies that aim to expand access to medication abortion including a national mixed-methods study on people’s interest in alternative models of medication abortion provision, a self-selection study for over-the-counter medication abortion, and a retrospective case-control study to understand the risk of ectopic pregnancy among people seeking medication abortion. In addition, Shelly is a member of ANSIRH’s Abortion Facility Database committee. Shelly is also dedicated to improving equity and diversity at ANSIRH, leading efforts through the Culture and Inclusion working group to foster belonging, safety, and community-building among its members. Shelly’s previous experience includes research on factors influencing people’s contraceptive choices and evaluation of adolescent school health programs. Shelly received her MPH from Columbia University’s Mailman School of Public Health, with an emphasis on population and family health.
October 29, 2022
Biggs MA, Driver M, Kaller S, Ralph LJ. Unwanted abortion disclosure and social support in the abortion decision and mental health symptoms: A cross-sectional survey. Contraception. October 2022; DOI: 10.1016/j.contraception.2022.10.007.
July 30, 2022
Kaller S, Ma M, Gurazada T, Baba F, Rafie S, Raine-Bennett T, Averbach S, Chen M, Berry E, Meckstroth KR, Grossman D. "No Big Deal”: A Qualitative Study of Pharmacists’ Perspectives on Dispensing Mifepristone for Medication Abortion. Women's Health Issues. July 2022; DOI: 10.1016/j.whi.2022.06.007.
April 11, 2022
Upadhyay UD, Chris Ahlbach, Kaller S, Clare Stewart, Isabel Muñoz, MPH. Trends In Self-Pay Charges And Insurance Acceptance For Abortion In The United States, 2017-20. Health Affairs. April 11, 2022; DOI: 10.1377/hlthaff.2021.01528.